ArticleJournal of inherited metabolic disease2023

CRISPR/Cas9-based double-strand oligonucleotide insertion strategy corrects metabolic abnormalities in murine glycogen storage disease type-Ia.

Ananya Samanta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.